HomeA2LC34 • BVMF
add
Alcon Inc
Nakaraang pagsara
R$55.05
Sakop ng taon
R$47.40 - R$56.64
Market cap
35.58B CHF
Average na Volume
1.00
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 2.47B | 0.57% |
Gastos sa pagpapatakbo | 1.05B | 3.94% |
Net na kita | 350.00M | 41.13% |
Net profit margin | 14.15 | 40.24% |
Kita sa bawat share | 0.73 | -6.41% |
EBITDA | 476.00M | -26.09% |
Aktuwal na % ng binabayarang buwis | 15.46% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.41B | 23.10% |
Kabuuang asset | 31.01B | 4.88% |
Kabuuang sagutin | 8.99B | 2.87% |
Kabuuang equity | 22.02B | — |
Natitirang share | 495.70M | — |
Presyo para makapag-book | 1.24 | — |
Return on assets | 2.68% | — |
Return on capital | 3.05% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 350.00M | 41.13% |
Cash mula sa mga operasyon | 384.00M | 12.61% |
Cash mula sa pag-invest | -578.00M | -165.14% |
Cash mula sa financing | -96.00M | -45.45% |
Net change in cash | -264.00M | -661.70% |
Malayang cash flow | 17.00M | -90.85% |
Tungkol
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Itinatag
1945
Headquarters
Website
Mga Empleyado
25,000
